Acquired haemophilia A treated with recombinant porcine factor VIII: a single centre UK experience
Br J Haematol
.
2020 May;189(4):e130-e133.
doi: 10.1111/bjh.16556.
Epub 2020 Mar 6.
Authors
Dalia Khan
1
,
Sayma Raza-Burton
1
,
Peter Baker
1
,
Sarah Harper
1
,
James Beavis
1
,
Michael Desborough
1
,
Susan Shapiro
1
Affiliation
1
Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Foundation Trust, NIHR Oxford Biomedical Research Centre, Oxford, UK.
PMID:
32141061
DOI:
10.1111/bjh.16556
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Aged
Aged, 80 and over
Animals
Factor VIII / pharmacology
Factor VIII / therapeutic use*
Female
Hemophilia A / drug therapy*
Humans
Male
Swine
United Kingdom
Substances
Factor VIII
Grants and funding
National Institute for Health Research/International
Oxford Biomedical Research Centre/International
DH_/Department of Health/United Kingdom